Study finds drinking coffee can delay onset of Alzheimer’s

A study of senior citizens in Florida found that drinking coffee could delay the onset of or help prevent Alzheimer’s disease.

The study, carried out on adults over the age of 65 in Miami and Tampa, found that those with higher levels of caffeine in their blood avoided the onset of Alzheimer’s in the two- to four-year period they were monitored.

Dr. Chuanhai Cao, a neuroscientist at the University of South Florida College of Pharmacy, said, “These intriguing results suggest that older adults with mild memory impairment who drink moderate levels of coffee — about three cups a day — will not convert to Alzheimer’s disease or at least will experience a substantial delay before converting to Alzheimer’s.”

Cao added, “The results from this study, along with our earlier studies in Alzheimer’s mice, are very consistent in indicating that moderate daily caffeine/coffee intake throughout adulthood should appreciably protect against Alzheimer’s disease later in life.”

The report, led by University of South Florida and University of Miami researchers, warned that 10 million Americans have some form of the condition.

It also found that moderate caffeine intake appeared to reduce the risk of other diseases associated with aging — including Parkinson’s disease, stroke, type 2 diabetes and breast cancer.

The study will be published Tuesday in the Journal of Alzheimer’s Disease.

Similar Posts

Peanut Butter and Alzheimer?

“Could a scoop of peanut butter and a ruler become that elusive test?” If you treat the elderly, or any member of the growing number of families devastated by Alzheimer’s disease, you may be asked some version of that question, as posed by CBS News, in the coming weeks. You can thank media coverage of…

Alzheimer’s Gene Effects May Show Up in Infancy

Infants and toddlers with the Alzheimer’s disease-associated APOE4 genotype already showed distinctive patterns of brain structure relative to other young children, researchers said. MRI scans carried out in 60 normally developing children, age 2 to 25 months, who carried the APOE epsilon-4 allele, showed smaller volumes of gray matter and and lower white matter myelin…

Ceramides in Blood May Signal Alzheimer’s Disease Risk

High levels of a family of lipids called ceramides in the blood may be predictive of developing Alzheimer’s disease, a new study suggests. Women with the highest levels of ceramides had a 10-fold higher risk of developing Alzheimer’s compared with those with the lowest levels, said Michelle M. Mielke, PhD, from the Mayo Clinic, Rochester,…

A Smell Test for Alzheimer’s?

May 25, 2012 – There is a large body of evidence for an association between hyposmia and Alzheimer’s dementia (AD), but the predictive value of olfactory dysfunction in the development of Alzheimer’s disease (AD) is uncertain, a new review of the topic concludes. “We establish through a systematic review the lack of proven evidence that…

Inflammation as a New Therapeutic Approach For Alzheimer’s Disease

In the next several decades the number of Alzheimer’s patients will continue to dramatically increase. Various teams of researchers worldwide are feverishly investigating precisely how the illness develops. Inflammation as a New Therapeutic Approach For Alzheimer’s Disease A team of scientists under the guidance of the University of Bonn and University of Massachusetts (USA) and…